[Table/Fig-3]:
Primary end point (success/failure).
| At 4 week | At 12 week | |||
|---|---|---|---|---|
| Success | Failure | Success | Failure | |
| Steroid group (n=47) | 32 (68.09%) | 15 (31.91%) | 28 (59.57%) | 19 (40.43%) |
| Saline group (n=46) | 8 (17.39%) | 38 (82.61%) | 22 (47.83%) | 24 (52.17%) |
| Intergroup difference | 50.69% | - | 11.75% | - |
| 95% CI for the difference | 33.44 to 67.94 | - | -8.38 to31.88 | - |
| Number needed to treat/harm | 2 | 9 | - | |
| p-value | 0.00 | - | 0.25 | - |